Skip to content
Ticarcillin
Ticar, Timentin (ticarcillin) is a small molecule pharmaceutical. Ticarcillin was first approved as Ticar on 1982-01-01. It is used to treat bacterial infections, infectious skin diseases, pseudomonas infections, respiratory tract infections, and soft tissue infections amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Clavulanate potassium
+
Ticarcillin disodium
Tradename
Company
Number
Date
Products
TIMENTINGSKN-050590 DISCN1985-04-01
3 products
TIMENTIN IN PLASTIC CONTAINERGSKN-050658 DISCN1989-12-15
1 products
Hide discontinued
Ticarcillin disodium
Tradename
Company
Number
Date
Products
TICARGSKN-050497 DISCN1982-01-01
5 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections—D001424A49
infectious skin diseases—D012874—
pseudomonas infectionsEFO_0001076D011552—
respiratory tract infections—D012141J06.9
soft tissue infections—D018461—
urinary tract infectionsEFO_0003103D014552N39.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01C: Beta-lactam antibacterials, penicillins
— J01CA: Penicillins with extended spectrum
— J01CA13: Ticarcillin
— J01CR: Combinations of penicillins, incl. beta-lactamase inhibitors
— J01CR03: Ticarcillin and beta-lactamase inhibitor
HCPCS
Code
Description
S0040
Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams
Clinical
Clinical Trials
13 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Partial epilepsiesD004828EFO_0004263———1—1
Social phobiaD000072861EFO_1001917F40.1———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Anxiety disordersD001008EFO_0006788F41.1——5——5
SchizophreniaD012559EFO_0000692F20——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cocaine-related disordersD019970F14—2———2
Opioid-related disordersD009293EFO_0005611F11—1———1
Obstructive sleep apneaD020181EFO_0003918G47.33—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AlcoholismD000437EFO_0003829F10.11————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EpilepsyD004827EFO_0000474G40.9————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTICARCILLIN
INNticarcillin
Description
Ticarcillin is a penicillin compound having a 6beta-[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino side-group. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of a ticarcillin(2-).
Classification
Small molecule
Drug classpenicillins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O
Identifiers
PDB—
CAS-ID34787-01-4
RxCUI10591
ChEMBL IDCHEMBL1449
ChEBI ID9587
PubChem CID36921
DrugBankDB01607
UNII IDF93UJX4SWT (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 6,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
695 adverse events reported
View more details